Your account is not claimed yet. You can sign up with ORCID to claim your account.

Hendra Gunosewoyo

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 10

Top Venues

International journal of molecular sciences

RSC advances

Current medicinal chemistry

Cancers

Curtin University

University of Sydney (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Curtin University

Australia

Senior Lecturer :: School of Pharmacy and Biomedical Sciences

Education History

University of Sydney

Australia

PHD :: School of Chemistry

Publications

Shahinda S R Alsayed, Hendra Gunosewoyo
Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug Targets. International journal of molecular sciences 24 (6) (2023)
Caitlin L Duncan, Hendra Gunosewoyo, Mauro Mocerino, Alan D Payne
Small Molecule Inhibitors of Human Papillomavirus: A Review of Research from 1997 to 2021. Current medicinal chemistry (2023)
Shahinda S R Alsayed, Hendra Gunosewoyo
Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug Targets. International journal of molecular sciences 24 (6) (2023)
Shahinda S R Alsayed, Hendra Gunosewoyo
Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug Targets. International journal of molecular sciences 24 (6) (2023)
Shahinda S R Alsayed, Amreena Suri, Anders W Bailey, Samuel Lane, Eryn L Werry, Chiang-Ching Huang, Li-Fang Yu, Michael Kassiou, Simone Treiger Sredni, Hendra Gunosewoyo
Synthesis and antitumour evaluation of indole-2-carboxamides against paediatric brain cancer cells. RSC medicinal chemistry 12 (11) (2021)
Shahinda S R Alsayed, Shichun Lun, Anders W Bailey, Amreena Suri, Chiang-Ching Huang, Mauro Mocerino, Alan Payne, Simone Treiger Sredni, William R Bishai, Hendra Gunosewoyo
Design, synthesis and evaluation of novel indole-2-carboxamides for growth inhibition of Mycobacterium tuberculosis and paediatric brain tumour cells. RSC advances 11 (26) (2021)
Shahinda S R Alsayed, Shichun Lun, Giuseppe Luna, Chau Chun Beh, Alan D Payne, Neil Foster, William R Bishai, Hendra Gunosewoyo
Design, synthesis, and biological evaluation of novel arylcarboxamide derivatives as anti-tubercular agents. RSC advances 10 (13) (2020)
Yue-Yang Ji, Zhi-Long Wang, Fang-Ning Pei, Jun-Jie Shi, Jiao-Jiao Li, Hendra Gunosewoyo, Fan Yang, Jie Tang, Xin Xie, Li-Fang Yu
Introducing nitrogen atoms to amidoalkylindoles: potent and selective cannabinoid type 2 receptor agonists with improved aqueous solubility. MedChemComm 10 (12) (2019)
Amreena Suri, Anders W Bailey, Maurício Temotheo Tavares, Hendra Gunosewoyo, Connor P Dyer, Alex T Grupenmacher, David R Piper, Robert A Horton, Tadanori Tomita, Alan P Kozikowski, Saktimayee M Roy, Simone T Sredni
Evaluation of Protein Kinase Inhibitors with PLK4 Cross-Over Potential in a Pre-Clinical Model of Cancer. International journal of molecular sciences 20 (9) (2019)
Mudra Binju, Monica Angelica Amaya-Padilla, Graeme Wan, Hendra Gunosewoyo, Yohan Suryo Rahmanto, Yu Yu
Therapeutic Inducers of Apoptosis in Ovarian Cancer. Cancers 11 (11) (2019)

Hendra Gunosewoyo.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hendra Gunosewoyo